BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: De Cassan C, Savarino E, Marson P, Tison T, Hatem G, Sturniolo GC, D’Incà R. Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. World J Gastroenterol 2014; 20(45): 17155-17162 [PMID: 25493030 DOI: 10.3748/wjg.v20.i45.17155]
URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17155.htm
Number Citing Articles
1
Wolfgang Kruis, Phuong Nguyen, Julia Morgenstern, Wolfgang Ramlow, Axel Dignaß, Andreas Stallmach, Uta Drebber. Novel Leucocyte/Thrombocyte Apheresis for Induction of Steroid-Free Remission in Ulcerative Colitis: A Controlled Randomized Pilot StudyJournal of Crohn's and Colitis 2019; 13(7): 949 doi: 10.1093/ecco-jcc/jjz005
2
Emre Gerçeker, Hakan Yüceyar, Elmas Kasap, Ufuk Demirci, Burcu Ceren Ekti, İsmet Aydoğdu, Mine Miskioğlu. Treatment of inflammatory bowel disease by leukocytapheresisTransfusion and Apheresis Science 2017; 56(3): 421 doi: 10.1016/j.transci.2017.03.016
3
Takayuki Yamamoto, Takayuki Iida, Kentaro Ikeya, Masaichi Kato, Ai Matsuura, Satoshi Tamura, Ryosuke Takano, Shinya Tani, Satoshi Osawa, Ken Sugimoto, Takahiro Shimoyama, Hiroyuki Hanai. A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitisClinical and Translational Gastroenterology 2018; 9(7): e170 doi: 10.1038/s41424-018-0037-0
4
Yoshikazu Kuboi, Miyuki Nishimura, Wataru Ikeda, Tomoya Nakatani, Yukie Seki, Yui Yamaura, Kana Ogawa, Akiko Hamaguchi, Kenzo Muramoto, Keiko Mizuno, Hideaki Ogasawara, Toshihiko Yamauchi, Nobuyuki Yasuda, Hiroshi Onodera, Toshio Imai. Blockade of the fractalkine–CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytesInternational Immunology 2019; 31(5): 287 doi: 10.1093/intimm/dxz006
5
Yoh Ishiguro, Toshihide Ohmori, Ken Umemura, Masahiro Iizuka. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort studyTherapeutic Apheresis and Dialysis 2021; 25(4): 502 doi: 10.1111/1744-9987.13594